Suppr超能文献

[前列腺癌筛查?唯有基于证据、风险调整且有序进行!]

[Prostate cancer screening? Only evidence-based, risk-adjusted, and organized!].

作者信息

Albers Peter, Becker Nikolaus

机构信息

Abteilung für Personalisierte Früherkennung des Prostatakarzinoms, Deutsches Krebsforschungszentrum (DKFZ) Heidelberg, C130, Im Neuenheimer Feld 581, 69120, Heidelberg, Deutschland.

Klinik für Urologie, Universitätsklinikum Düsseldorf, Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Deutschland.

出版信息

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 Sep;67(9):1047-1053. doi: 10.1007/s00103-024-03916-3. Epub 2024 Aug 5.

Abstract

In view of a recent recommendation of the European Commission to conceptualize novel screening approaches for lung, gastric, and prostate cancer, Germany is also invoked to revise its prostate early detection program. This discussion article provides an overview of new findings on prostate cancer screening, which suggest an organized and risk-adapted screening approach. Based on the German risk-adapted screening trial PROBASE, together with recently published data on organized screening programs in Europe, model projects should be established to determine the specific modalities for a new organized and risk-adapted prostate cancer screening program.

摘要

鉴于欧盟委员会最近提出的关于构思肺癌、胃癌和前列腺癌新型筛查方法的建议,德国也被呼吁修订其前列腺癌早期检测计划。这篇讨论文章概述了前列腺癌筛查的新发现,这些发现表明应采用有组织且根据风险调整的筛查方法。基于德国的风险适应性筛查试验PROBASE以及欧洲最近公布的有组织筛查计划的数据,应建立示范项目,以确定新的有组织且根据风险调整的前列腺癌筛查计划的具体模式。

相似文献

1
[Prostate cancer screening? Only evidence-based, risk-adjusted, and organized!].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 Sep;67(9):1047-1053. doi: 10.1007/s00103-024-03916-3. Epub 2024 Aug 5.
2
[Prostate cancer screening-current overview].
Radiologie (Heidelb). 2024 Jun;64(6):479-487. doi: 10.1007/s00117-024-01312-1. Epub 2024 May 14.
3
Adherence to a risk-adapted screening strategy for prostate cancer: First results of the PROBASE trial.
Int J Cancer. 2023 Mar 1;152(5):854-864. doi: 10.1002/ijc.34295. Epub 2022 Oct 5.
4
[Risk-adapted early detection program for prostate cancer 2.0-position paper of the German Society of Urology 2024].
Urologie. 2024 Sep;63(9):893-898. doi: 10.1007/s00120-024-02437-w. Epub 2024 Aug 12.
6
[Risk-adapted prostate cancer screening-update 2021].
Urologe A. 2021 May;60(5):592-601. doi: 10.1007/s00120-021-01505-9. Epub 2021 Apr 1.
7
Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.
Ont Health Technol Assess Ser. 2015 May 1;15(10):1-64. eCollection 2015.
8
[PSA screening].
Dtsch Med Wochenschr. 2015 Sep;140(19):1435-7. doi: 10.1055/s-0041-102939. Epub 2015 Sep 24.
9
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710.

引用本文的文献

1
Cost effectiveness analysis of prostate cancer screening strategies in Germany: A microsimulation study.
Int J Cancer. 2025 Oct 15;157(8):1662-1679. doi: 10.1002/ijc.35513. Epub 2025 Jul 16.

本文引用的文献

1
Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE Trial.
Eur Urol. 2024 Dec;86(6):493-500. doi: 10.1016/j.eururo.2024.04.030. Epub 2024 May 15.
2
Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trial.
JAMA. 2024 May 7;331(17):1452-1459. doi: 10.1001/jama.2024.3841.
3
A Pragmatic Approach to Prostate Cancer Screening.
JAMA. 2024 May 7;331(17):1448-1450. doi: 10.1001/jama.2024.4089.
5
Magnetic Resonance Imaging in Prostate Cancer Screening: A Systematic Review and Meta-Analysis.
JAMA Oncol. 2024 Jun 1;10(6):745-754. doi: 10.1001/jamaoncol.2024.0734.
6
Screening for Prostate Cancer With Modern Diagnostics-Another Piece of the Puzzle.
JAMA Netw Open. 2024 Feb 5;7(2):e2354544. doi: 10.1001/jamanetworkopen.2023.54544.
8
Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment.
NEJM Evid. 2023 Apr;2(4):EVIDoa2300018. doi: 10.1056/EVIDoa2300018. Epub 2023 Mar 11.
9
Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old Men.
Eur Urol. 2024 Mar;85(3):207-214. doi: 10.1016/j.eururo.2023.11.013. Epub 2023 Dec 1.
10
Comparative effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measures.
Clin Transl Radiat Oncol. 2023 Oct 29;44:100694. doi: 10.1016/j.ctro.2023.100694. eCollection 2024 Jan.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验